Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Observational × Epirubicin × Clear all

Status

Unknown 2 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 14 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Observation 17 Surveys and Questionnaires 13 Blood Specimen Collection 13 Drug Therapy 11 Surgical Procedures, Operative 8 Immune Checkpoint Inhibitors 7 Neoadjuvant Therapy 6 Watchful Waiting 5 Docetaxel 5 Positron Emission Tomography Computed Tomography 4 Letrozole 4 Fluorodeoxyglucose F18 4 Bevacizumab 4 palbociclib 3 envafolimab 3 darolutamide 3 Tamoxifen 3 Radiotherapy 3 Radiofrequency Ablation 3 Radiation 3 Interviews as Topic 3 Indocyanine Green 3 Immunotherapy 3 Hematologic Tests 3 Endoscopic Mucosal Resection 3 tislelizumab 2 pertuzumab 2 obinutuzumab 2 neratinib 2 camrelizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05131893 2021-11-23

Neoadjuvant Treatment of Breast Cancer

National Institute of Oncology, Hungary

Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡